US Patent Issued to Regeneron Pharmaceuticals on Sept. 1 for "Anti-CD45 antibody drug conjugates and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,097, issued on Sept. 1, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Anti-CD45 antibody drug conjugates and uses thereof" was invented by Anthony Boitano (Newton, Mass.), Michael Cooke (Boston), Geoffrey O. Gillard (Harvard, Mass.), Charlotte Fenton McDonagh (Winchester, Mass.), Rahul Palchaudhuri (Somerville, Mass.) and Bradley R. Pearse (Somerville, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides anti-CD45 antibody drug conjugates (ADCs), and methods of use thereof. In one embodiment, the invention provides methods of depleting a population of CD45+ cells from a subject, by administration of an ant...